Cargando…
Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study
BACKGROUND: The purpose of this study was to assess changes in gastrointestinal symptom severity in patients with autoimmune disease who were switched from mycophenolate mofetil to enteric-coated mycophenolate sodium (EC-MPS). METHODS: In this national, explorative, single-arm study, 111 patients we...
Autores principales: | Manger, Bernhard, Hiepe, Falk, Schneider, Matthias, Worm, Margitta, Wimmer, Peter, Paulus, Eva-Maria, Schwarting, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516030/ https://www.ncbi.nlm.nih.gov/pubmed/26229499 http://dx.doi.org/10.2147/CEG.S81922 |
Ejemplares similares
-
Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease
por: Jones, Rachel B., et al.
Publicado: (2014) -
Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022) -
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
por: Gardiner, Kyle M., et al.
Publicado: (2018) -
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
por: Jia, Yichen, et al.
Publicado: (2018) -
Autoimmune Gastritis Treated With Mycophenolate Mofetil
por: Harb, Ali H., et al.
Publicado: (2020)